Global Diabetic Retinopathy Market is
expected to reach USD 10.11 billion by 2022, according to a new study by Grand
View Research Inc. Diabetic retinopathy is considered as a serious sight
threatening complication that results due to long term diabetes. The treatment
line selection for diabetic retinopathy depends on the severity of the
condition and may require intraocular injections, anti VEGF drugs, laser
surgery or vitrectomy. Increasing incidences of diabetes, rising geriatric
population base and the growing demand for early detection are some high impact
rendering drivers of the diabetic retinopathy market. Furthermore, improving
healthcare infrastructure, rising demand for cost-effective and safe treatment
and rising focus of market players on emerging nations such as India and China
are also anticipated to propel market growth. Presence of supportive government
initiatives such as the Queen Elizabeth Diamond Jubilee Trust, which is taking
initiatives for increasing patient awareness levels in order to promote regular
retinal screening and early laser surgery to prevent permanent visual
impairment and Ophthalmic Society of South Africa which works towards the
improvement of reimbursement policies are anticipated to fuel the growth of the
diabetic retinopathy market over the forecast period.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market
Further key findings from the study suggest:
·
Anti VEGF is identified as the most
attractive sub segment of the diabetic retinopathy market, growing at a rate of
over 6.0% over the forecast period owing to, the rising incidences of diabetes
and high efficacy rates
·
The non proliferative diabetic retinopathy
segment accounted for the largest market share in 2014. The growing geriatric
population and rising incidences of blindness caused due to diabetes are some
key factors accounting for its large share. Furthermore, the increasing demand
for regular retinal screening for long time diabetic patients is also expected
to boost segment growth.
·
The North American diabetic retinopathy
market accounted for over 35.0% of the revenue in 2014 on account of, the
presence of high diagnostic and therapeutic rates in the U.S. The rising
patient awareness levels and the presence of favorable government initiatives
encouraging regular retinal screening is expected to drive regional market
growth.
·
The Asia Pacific diabetic retinopathy
market is likely to witness lucrative growth over the forecast period due to,
the presence of unmet needs in the developing economies such as China and
India. Presence of favorable government initiatives to enhance retinal
screening rates and improving healthcare infrastructure are also expected to
contribute towards rapid market growth.
·
Some key players of the diabetic
retinopathy market include Bayer Healthcare, Novartis AG, ThromboGenics,
Regeneron Pharmaceuticals Inc., Actavis Plc, Alimera Sciences, BCN Peptides and
Kowa Group
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
For the purpose of this
study, Grand View Research has segmented the global diabetic retinopathy market
on the basis of type, management and region:
Global Diabetic Retinopathy Type Outlook (Revenue,
USD Million, 2012 - 2022)
·
Proliferative
·
Non proliferative
Global Diabetic Retinopathy Management Outlook
(Revenue, USD Million, 2012 - 2022)
·
Anti VEGF
·
Intraocular steroid injection
·
Laser surgery
·
Vitrectomy
Diabetic Retinopathy Regional Outlook (Revenue, USD
Million, 2012 - 2022)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
o Rest of Europe
·
Asia Pacific
o Japan
o China
o Rest of Asia Pacific
·
Latin America
o Brazil
o Rest of Latin America
·
Middle East and Africa (MEA)
o South Africa
o Rest of Middle East and Africa
View Press Release of this research
report by Grand View Research: http://www.grandviewresearch.com/press-release/global-diabetic-retinopathy-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and fact-based
research across a range of industries, from technology to chemicals, materials
and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment